Bruce Ponder
机构: professor of oncology Cambridge university
每年引用次数
引用次数
引用: 87,056
H-指数: 140
I10-指数 : 403
出版物: 696
The human chromosome 9 region orthologous to Mcs5a, a rat composite modifier locus, contains a breast cancer risk allele.
Beth A. Aperavich , Amy Trentham-Dietz , David J. Samuelson , Jill D. Haag
Cancer Research 66 1268 -1268
2006
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Discussion
S. Cantor , R. Scully , D. Silver , D. M. Livingston
Cancer Research 59 ( 7)
113
1999
Low penetrance susceptibility genes for breast cancer
B. Ponder , Annika Auranen , Alison Dunning , Doug Easton
European Journal of Cancer 37
2001
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies
A. Rajan , A. Berns , U. Ringborg , J. Celis
Molecular Oncology 10 ( 5) 645 -651
5
2016
Genetics and cancer.
W.K. Cavenee , B. Ponder , E. Solomon
European Journal of Cancer and Clinical Oncology 27 ( 12) 1706 -1707
1
1991
A matched control study of familial epithelial ovarian cancer: Patient characteristics, response to chemotherapy and outcome
J. Chang , I. Fryatt , B. Ponder , C. Fisher
Annals of Oncology 6 ( 1) 80 -82
24
1995
Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting
M. Watson , S. M. Lloyd , R. Eeles , B. Ponder
Psycho-oncology 5 ( 3) 233 -239
44
1996
Report of the committee on chromosome and gene loss in human neoplasia
B.R. Seizinger , H.P. Klinger , C. Junien , Y. Nakamura
Cytogenetic and Genome Research 58 1080 -1096
152
1991
41 Clinical Applications of Genome-wide Association Study Data - Lessons from Breast and Prostate Cancer
B. Ponder , P. Pharoah , N. Pashayan
European Journal of Cancer 48 S9 -S10
2012
Cytokine polymorphism frequencies in a population from Norfolk, England
W.M. Howell , E.A. Bulpitt , A. Dunning , B. Ponder
Human Immunology 65 ( 9) 933 -934
2004
Novel regulators of ESR1 activity
T. Campbell , B. Ponder , K. Meyer
European Journal of Cancer 61
2016
Genetic Events in Development of Multiple Endocrine Neoplasia Type 2
B. Ponder
Karger Publishers 39 151 -156
1990
Genetic analysis of NF1: Identification of close flanking markers on chromosome 17
P.R. Fain , D.F. Barker , D.E. Goldgar , E. Wright
Genomics 1 ( 4) 340 -345
40
1987
Linkage of NF1 to 12 chromosome 17 markers: a summary of eight concurrent reports.
M.H. Skolnick , B. Ponder , B. Seizinger
Genomics 1 ( 4) 382 -383
16
1987
52. Development of network of cancer family syndrome registries in eastern Europe
J. Lubinski , P. Boesze , P. Elsakov , L. Foretova
Reports of Practical Oncology & Radiotherapy 6 ( 1) 51 -51
2001
P1.11-04 Utilizing DNA Repair Activity Biomarkers for Lung Cancer Risk Assessment and Early Detection
T. Paz-Elizur , Y. Leitner-Dagan , K. Meyer , B. Markus
Journal of Thoracic Oncology 14 ( 10)
2019
P1.04-22 Potential DNA Repair Biomarker for Response to Immunotherapy of Lung Cancer Patients
Z. Livneh , T. Paz-Elizur , Y. Leitner-Dagan , K. Meyer
Journal of Thoracic Oncology 14 ( 10)
2019
Genetic testing in breast/ovarian cancer (BRCA1) families.
M. Watson , V. Murday , S. Lloyd , B. Ponder
The Lancet 346 ( 8974) 583 -583
42
1995
Genetic Testing for Cancer Risk
B. Ponder
Science 278 ( 5340) 1050 -1054
104
1997
The von Recklinghausen neurofibromatosis region on chromosome 17--genetic and physical maps come into focus.
Ponder Ba , Collins Fs , Seizinger Br , Epstein Cj
American Journal of Human Genetics 44 ( 1) 1 -5
45
1989